126 related articles for article (PubMed ID: 7706525)
21. Aggregation of lipoprotein(a) to apolipoprotein A-I underlying HDL dysfunction as a major coronary risk factor.
Onat A; Can G; Murat S; Ciçek G; Örnek E; Yüksel H
Anadolu Kardiyol Derg; 2013 Sep; 13(6):543-51. PubMed ID: 23835300
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
[TBL] [Abstract][Full Text] [Related]
23. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
[TBL] [Abstract][Full Text] [Related]
24. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.
O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Holmes D; Kottke BA
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):228-31. PubMed ID: 7749830
[TBL] [Abstract][Full Text] [Related]
25. [Importance of lipoprotein(a) in patients with ischemic heart disease].
Nakamura Y; Yokoi Y; Hamaguchi H; Toyonaga T; Kondo T; Takami S; Kubo M; Matsuzawa Y
J Cardiol; 1992; 22(2-3):319-23. PubMed ID: 1339790
[TBL] [Abstract][Full Text] [Related]
26. Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism.
Konerman M; Kulkarni K; Toth PP; Jones SR
J Clin Lipidol; 2012; 6(1):27-32. PubMed ID: 22264571
[TBL] [Abstract][Full Text] [Related]
27. Serum Lp AI lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjects.
Lecerf JM; Masson A; Fruchart JC; Bard JM
Diabetes Metab; 1996 Oct; 22(5):331-40. PubMed ID: 8896995
[TBL] [Abstract][Full Text] [Related]
28. [A four-year prospective study on the influence of serum elevated lipoprotein (a) concentration on ischemic heart disease and cerebral infarction in elderly patients with type 2 diabetes].
Suzuki T; Oba K; Igari Y; Matsumura N; Inuzuka Y; Kigawa Y; Ajiro Y; Okazaki K; Nakano H; Metori S
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):507-13. PubMed ID: 11523163
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein(a): an independent risk factor for ischemic heart disease that is dependent on triglycerides in subjects with type 2 diabetes mellitus.
Albahrani A; Alkindi M; Marks E; Alyahyaee S; Shenkin A
Lipids Health Dis; 2007 Oct; 6():26. PubMed ID: 17908332
[TBL] [Abstract][Full Text] [Related]
30. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
31. Lp(a) levels in patients undergoing aorto-coronary bypass surgery.
Averna MR; Barbagallo CM; Ocello S; Doria O; Davì G; Scafidi V; Albiero R; Notarbartolo A
Eur Heart J; 1992 Oct; 13(10):1405-9. PubMed ID: 1396816
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia.
Watts GF; Kearney EM; Taub NA; Slavin BM
J Clin Pathol; 1993 Mar; 46(3):267-70. PubMed ID: 8463422
[TBL] [Abstract][Full Text] [Related]
33. Serum LpAI lipoprotein particles in diabetic patients with and without renal lesions of different grades.
Peynet J; Guillausseau PJ; Legrand A; Altman JJ; Flourie F; Chanson P; Poupon J; N'Guyen M; Warnet A; Lubetzki J
Diabete Metab; 1993; 19(4):355-60. PubMed ID: 8293861
[TBL] [Abstract][Full Text] [Related]
34. Quantification of apolipoprotein AI-containing lipoprotein particles in non-insulin-dependent diabetes mellitus.
Contiero E; Ferrari R; Vaselli GM; Folin M
Diabetes Res Clin Pract; 1998 Mar; 39(3):201-9. PubMed ID: 9649952
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of serum lipoproteins after coronary artery bypass surgery.
Shaukat N; Ashraf SS; Mackness MI; Mbewu AD; Bhatnagar D; Durrington PN
QJM; 1994 Sep; 87(9):539-45. PubMed ID: 7953502
[TBL] [Abstract][Full Text] [Related]
37. Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction.
Sewdarsen M; Desai RK; Vythilingum S; Shah N; Rajput MC
Postgrad Med J; 1991 Feb; 67(784):159-64. PubMed ID: 2041847
[TBL] [Abstract][Full Text] [Related]
38. Serum lipoprotein (a) levels in men with peripheral vascular disease.
Nogués X; Sentí M; Pedro-Botet J; Rubiés-Prat J; Vidal-Barraquer F
Angiology; 1991 Aug; 42(8):659-64. PubMed ID: 1832526
[TBL] [Abstract][Full Text] [Related]
39. Apolipoproteins and ischaemic heart disease: implications for screening.
Wald NJ; Law M; Watt HC; Wu T; Bailey A; Johnson AM; Craig WY; Ledue TB; Haddow JE
Lancet; 1994 Jan; 343(8889):75-9. PubMed ID: 7903777
[TBL] [Abstract][Full Text] [Related]
40. The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
Benes P; Muzík J; Benedík J; Znojil V; Vácha J
Hum Biol; 2002 Feb; 74(1):129-36. PubMed ID: 11931574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
